GEMI5_HUMAN - dbPTM
GEMI5_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID GEMI5_HUMAN
UniProt AC Q8TEQ6
Protein Name Gem-associated protein 5
Gene Name GEMIN5
Organism Homo sapiens (Human).
Sequence Length 1508
Subcellular Localization Nucleus, nucleoplasm . Nucleus, gem . Cytoplasm . Found both in the nucleoplasm and in nuclear bodies called gems (Gemini of Cajal bodies) that are often in proximity to Cajal (coiled) bodies. Also found in the cytoplasm.
Protein Description Required for the assembly of the SMN complex that plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. [PubMed: 16857593]
Protein Sequence MGQEPRTLPPSPNWYCARCSDAVPGGLFGFAARTSVFLVRVGPGAGESPGTPPFRVIGELVGHTERVSGFTFSHHPGQYNLCATSSDDGTVKIWDVETKTVVTEHALHQHTISTLHWSPRVKDLIVSGDEKGVVFCYWFNRNDSQHLFIEPRTIFCLTCSPHHEDLVAIGYKDGIVVIIDISKKGEVIHRLRGHDDEIHSIAWCPLPGEDCLSINQEETSEEAEITNGNAVAQAPVTKGCYLATGSKDQTIRIWSCSRGRGVMILKLPFLKRRGGGIDPTVKERLWLTLHWPSNQPTQLVSSCFGGELLQWDLTQSWRRKYTLFSASSEGQNHSRIVFNLCPLQTEDDKQLLLSTSMDRDVKCWDIATLECSWTLPSLGGFAYSLAFSSVDIGSLAIGVGDGMIRVWNTLSIKNNYDVKNFWQGVKSKVTALCWHPTKEGCLAFGTDDGKVGLYDTYSNKPPQISSTYHKKTVYTLAWGPPVPPMSLGGEGDRPSLALYSCGGEGIVLQHNPWKLSGEAFDINKLIRDTNSIKYKLPVHTEISWKADGKIMALGNEDGSIEIFQIPNLKLICTIQQHHKLVNTISWHHEHGSQPELSYLMASGSNNAVIYVHNLKTVIESSPESPVTITEPYRTLSGHTAKITSVAWSPHHDGRLVSASYDGTAQVWDALREEPLCNFRGHRGRLLCVAWSPLDPDCIYSGADDFCVHKWLTSMQDHSRPPQGKKSIELEKKRLSQPKAKPKKKKKPTLRTPVKLESIDGNEEESMKENSGPVENGVSDQEGEEQAREPELPCGLAPAVSREPVICTPVSSGFEKSKVTINNKVILLKKEPPKEKPETLIKKRKARSLLPLSTSLDHRSKEELHQDCLVLATAKHSRELNEDVSADVEERFHLGLFTDRATLYRMIDIEGKGHLENGHPELFHQLMLWKGDLKGVLQTAAERGELTDNLVAMAPAAGYHVWLWAVEAFAKQLCFQDQYVKAASHLLSIHKVYEAVELLKSNHFYREAIAIAKARLRPEDPVLKDLYLSWGTVLERDGHYAVAAKCYLGATCAYDAAKVLAKKGDAASLRTAAELAAIVGEDELSASLALRCAQELLLANNWVGAQEALQLHESLQGQRLVFCLLELLSRHLEEKQLSEGKSSSSYHTWNTGTEGPFVERVTAVWKSIFSLDTPEQYQEAFQKLQNIKYPSATNNTPAKQLLLHICHDLTLAVLSQQMASWDEAVQALLRAVVRSYDSGSFTIMQEVYSAFLPDGCDHLRDKLGDHQSPATPAFKSLEAFFLYGRLYEFWWSLSRPCPNSSVWVRAGHRTLSVEPSQQLDTASTEETDPETSQPEPNRPSELDLRLTEEGERMLSTFKELFSEKHASLQNSQRTVAEVQETLAEMIRQHQKSQLCKSTANGPDKNEPEVEAEQPLCSSQSQCKEEKNEPLSLPELTKRLTEANQRMAKFPESIKAWPFPDVLECCLVLLLIRSHFPGCLAQEMQQQAQELLQKYGNTKTYRRHCQTFCM
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
48PhosphorylationVGPGAGESPGTPPFR
ECCCCCCCCCCCCCE
27.9329255136
51PhosphorylationGAGESPGTPPFRVIG
CCCCCCCCCCCEEHH
31.0429255136
118PhosphorylationTISTLHWSPRVKDLI
CHHHCCCCCHHHEEE
7.6524719451
122UbiquitinationLHWSPRVKDLIVSGD
CCCCCHHHEEEEECC
48.36-
127PhosphorylationRVKDLIVSGDEKGVV
HHHEEEEECCCCEEE
33.27-
144PhosphorylationYWFNRNDSQHLFIEP
EEECCCCCCCEEECC
24.0520873877
247AcetylationCYLATGSKDQTIRIW
CEEECCCCCCEEEEE
56.0226051181
247UbiquitinationCYLATGSKDQTIRIW
CEEECCCCCCEEEEE
56.02-
260MethylationIWSCSRGRGVMILKL
EEEECCCCCEEEEEC
33.16-
273MethylationKLPFLKRRGGGIDPT
ECCCHHHCCCCCCCH
46.66-
282AcetylationGGIDPTVKERLWLTL
CCCCCHHHHEEEEEE
39.3326051181
282UbiquitinationGGIDPTVKERLWLTL
CCCCCHHHHEEEEEE
39.3321906983
320AcetylationLTQSWRRKYTLFSAS
CCHHHHHHEEEEECC
33.7326051181
345PhosphorylationFNLCPLQTEDDKQLL
EEECCCCCCCHHHHH
49.4122817900
354PhosphorylationDDKQLLLSTSMDRDV
CHHHHHHHCCCCCCC
20.5725072903
355PhosphorylationDKQLLLSTSMDRDVK
HHHHHHHCCCCCCCC
28.2125072903
356PhosphorylationKQLLLSTSMDRDVKC
HHHHHHCCCCCCCCC
18.4725072903
413UbiquitinationVWNTLSIKNNYDVKN
EEEEEEECCCCCCCH
35.45-
419AcetylationIKNNYDVKNFWQGVK
ECCCCCCCHHHHHHH
43.4626051181
419UbiquitinationIKNNYDVKNFWQGVK
ECCCCCCCHHHHHHH
43.46-
426AcetylationKNFWQGVKSKVTALC
CHHHHHHHHHHEEEE
51.9225953088
428MalonylationFWQGVKSKVTALCWH
HHHHHHHHHEEEEEC
37.5826320211
437PhosphorylationTALCWHPTKEGCLAF
EEEEECCCCCCCEEE
28.9225599653
438AcetylationALCWHPTKEGCLAFG
EEEECCCCCCCEEEE
57.4726051181
450AcetylationAFGTDDGKVGLYDTY
EEECCCCCEECEECC
39.8726051181
450UbiquitinationAFGTDDGKVGLYDTY
EEECCCCCEECEECC
39.87-
460AcetylationLYDTYSNKPPQISST
CEECCCCCCCCCCEE
52.7326051181
460UbiquitinationLYDTYSNKPPQISST
CEECCCCCCCCCCEE
52.73-
470UbiquitinationQISSTYHKKTVYTLA
CCCEEECCCEEEEEE
39.46-
474PhosphorylationTYHKKTVYTLAWGPP
EECCCEEEEEEECCC
10.9825884760
516PhosphorylationQHNPWKLSGEAFDIN
ECCCCCCCCCEECHH
30.7523312004
524AcetylationGEAFDINKLIRDTNS
CCEECHHHHHCCCCC
45.7026051181
524UbiquitinationGEAFDINKLIRDTNS
CCEECHHHHHCCCCC
45.70-
531PhosphorylationKLIRDTNSIKYKLPV
HHHCCCCCCEEECCC
23.6628857561
533AcetylationIRDTNSIKYKLPVHT
HCCCCCCEEECCCCC
35.8326051181
535AcetylationDTNSIKYKLPVHTEI
CCCCCEEECCCCCEE
41.1126051181
535UbiquitinationDTNSIKYKLPVHTEI
CCCCCEEECCCCCEE
41.11-
616O-linked_GlycosylationIYVHNLKTVIESSPE
EEEEEEEEEEECCCC
29.8630059200
620O-linked_GlycosylationNLKTVIESSPESPVT
EEEEEEECCCCCCCE
39.8230059200
620PhosphorylationNLKTVIESSPESPVT
EEEEEEECCCCCCCE
39.8223186163
621PhosphorylationLKTVIESSPESPVTI
EEEEEECCCCCCCEE
21.6425850435
624O-linked_GlycosylationVIESSPESPVTITEP
EEECCCCCCCEECCC
28.2330059200
624PhosphorylationVIESSPESPVTITEP
EEECCCCCCCEECCC
28.2321815630
627PhosphorylationSSPESPVTITEPYRT
CCCCCCCEECCCEEE
26.0923186163
643PhosphorylationSGHTAKITSVAWSPH
CCCEEEEEEEEECCC
19.2220873877
644PhosphorylationGHTAKITSVAWSPHH
CCEEEEEEEEECCCC
17.2020873877
648PhosphorylationKITSVAWSPHHDGRL
EEEEEEECCCCCCCE
12.4820873877
657PhosphorylationHHDGRLVSASYDGTA
CCCCCEEEEEECCCH
18.9827050516
724UbiquitinationHSRPPQGKKSIELEK
CCCCCCCCCCHHHHH
37.79-
726PhosphorylationRPPQGKKSIELEKKR
CCCCCCCCHHHHHHH
25.4421815630
735PhosphorylationELEKKRLSQPKAKPK
HHHHHHHCCCCCCCC
48.7728176443
748PhosphorylationPKKKKKPTLRTPVKL
CCCCCCCCCCCCEEE
37.4430576142
751PhosphorylationKKKPTLRTPVKLESI
CCCCCCCCCEEEEEC
35.2325159151
754SumoylationPTLRTPVKLESIDGN
CCCCCCEEEEECCCC
47.98-
754AcetylationPTLRTPVKLESIDGN
CCCCCCEEEEECCCC
47.9823236377
754SumoylationPTLRTPVKLESIDGN
CCCCCCEEEEECCCC
47.9828112733
754UbiquitinationPTLRTPVKLESIDGN
CCCCCCEEEEECCCC
47.98-
757PhosphorylationRTPVKLESIDGNEEE
CCCEEEEECCCCCHH
36.0928355574
765PhosphorylationIDGNEEESMKENSGP
CCCCCHHHHHCCCCC
38.1321815630
770PhosphorylationEESMKENSGPVENGV
HHHHHCCCCCCCCCC
45.6328731282
778PhosphorylationGPVENGVSDQEGEEQ
CCCCCCCCCHHHHHH
34.6719664994
800PhosphorylationCGLAPAVSREPVICT
CCCCCCCCCCCEEEE
32.7920068231
806GlutathionylationVSREPVICTPVSSGF
CCCCCEEEECCCCCC
3.4222555962
807PhosphorylationSREPVICTPVSSGFE
CCCCEEEECCCCCCC
18.6625159151
810O-linked_GlycosylationPVICTPVSSGFEKSK
CEEEECCCCCCCCCE
26.4130059200
810PhosphorylationPVICTPVSSGFEKSK
CEEEECCCCCCCCCE
26.4121815630
811PhosphorylationVICTPVSSGFEKSKV
EEEECCCCCCCCCEE
47.9724732914
815AcetylationPVSSGFEKSKVTINN
CCCCCCCCCEEEECC
54.0026051181
815MethylationPVSSGFEKSKVTINN
CCCCCCCCCEEEECC
54.00-
838PhosphorylationPPKEKPETLIKKRKA
CCCCCCCHHHHHHHH
42.1629214152
847PhosphorylationIKKRKARSLLPLSTS
HHHHHHHHHCCCCCC
38.8325159151
852PhosphorylationARSLLPLSTSLDHRS
HHHHCCCCCCCCCCC
17.6320873877
853PhosphorylationRSLLPLSTSLDHRSK
HHHCCCCCCCCCCCH
40.7821712546
854PhosphorylationSLLPLSTSLDHRSKE
HHCCCCCCCCCCCHH
28.5525159151
859PhosphorylationSTSLDHRSKEELHQD
CCCCCCCCHHHHHHH
40.7920873877
860AcetylationTSLDHRSKEELHQDC
CCCCCCCHHHHHHHH
55.9826051181
860MalonylationTSLDHRSKEELHQDC
CCCCCCCHHHHHHHH
55.9832601280
860UbiquitinationTSLDHRSKEELHQDC
CCCCCCCHHHHHHHH
55.98-
867GlutathionylationKEELHQDCLVLATAK
HHHHHHHHHHHHHHH
1.9722555962
897PhosphorylationRFHLGLFTDRATLYR
HHHHCCCCCCHHEEE
29.62-
911AcetylationRMIDIEGKGHLENGH
EEEECCCCCCHHCCC
30.3019824993
933UbiquitinationMLWKGDLKGVLQTAA
HHCCCCHHHHHHHHH
52.2721906983
978PhosphorylationQLCFQDQYVKAASHL
HHHCCHHHHHHHHHH
16.5328152594
983PhosphorylationDQYVKAASHLLSIHK
HHHHHHHHHHHHHHH
21.3720860994
10122-HydroxyisobutyrylationREAIAIAKARLRPED
HHHHHHHHHCCCCCC
28.11-
1012UbiquitinationREAIAIAKARLRPED
HHHHHHHHHCCCCCC
28.11-
1026PhosphorylationDPVLKDLYLSWGTVL
CCHHHHHHCCCCCEE
14.60-
1039PhosphorylationVLERDGHYAVAAKCY
EEEECCCEEEEEEEE
14.3227642862
1053PhosphorylationYLGATCAYDAAKVLA
ECCCHHHHHHHHHHH
14.3022817900
1057AcetylationTCAYDAAKVLAKKGD
HHHHHHHHHHHHCCC
39.2326051181
1122S-palmitoylationQGQRLVFCLLELLSR
HHHHHHHHHHHHHHH
3.1029575903
1128PhosphorylationFCLLELLSRHLEEKQ
HHHHHHHHHHHHHHH
30.2224719451
11342-HydroxyisobutyrylationLSRHLEEKQLSEGKS
HHHHHHHHHHCCCCC
47.35-
1134AcetylationLSRHLEEKQLSEGKS
HHHHHHHHHHCCCCC
47.3526051181
1165UbiquitinationERVTAVWKSIFSLDT
HHHHHHHHHHHCCCC
27.37-
1182UbiquitinationQYQEAFQKLQNIKYP
HHHHHHHHHHCCCCC
45.66-
1187AcetylationFQKLQNIKYPSATNN
HHHHHCCCCCCCCCC
59.6726051181
1187UbiquitinationFQKLQNIKYPSATNN
HHHHHCCCCCCCCCC
59.6721906983
1188PhosphorylationQKLQNIKYPSATNNT
HHHHCCCCCCCCCCC
9.9124114839
1190PhosphorylationLQNIKYPSATNNTPA
HHCCCCCCCCCCCHH
44.6428152594
1192PhosphorylationNIKYPSATNNTPAKQ
CCCCCCCCCCCHHHH
33.0830622161
1195PhosphorylationYPSATNNTPAKQLLL
CCCCCCCCHHHHHHH
27.0524114839
1261AcetylationGCDHLRDKLGDHQSP
CCHHHHHHHCCCCCC
48.1926051181
1267PhosphorylationDKLGDHQSPATPAFK
HHHCCCCCCCCHHHH
17.0625159151
1270PhosphorylationGDHQSPATPAFKSLE
CCCCCCCCHHHHHHH
20.6625159151
1309PhosphorylationWVRAGHRTLSVEPSQ
EEEECCCEEEECHHH
20.0823663014
1311PhosphorylationRAGHRTLSVEPSQQL
EECCCEEEECHHHHC
24.6623663014
1315PhosphorylationRTLSVEPSQQLDTAS
CEEEECHHHHCCCCC
19.6323663014
1320PhosphorylationEPSQQLDTASTEETD
CHHHHCCCCCCCCCC
30.9723663014
1322PhosphorylationSQQLDTASTEETDPE
HHHCCCCCCCCCCCC
38.1423663014
1323PhosphorylationQQLDTASTEETDPET
HHCCCCCCCCCCCCC
35.0623663014
1326PhosphorylationDTASTEETDPETSQP
CCCCCCCCCCCCCCC
51.0928348404
1330PhosphorylationTEETDPETSQPEPNR
CCCCCCCCCCCCCCC
37.7418691976
1331PhosphorylationEETDPETSQPEPNRP
CCCCCCCCCCCCCCC
41.9229978859
1339PhosphorylationQPEPNRPSELDLRLT
CCCCCCCCHHCEEEC
47.7827251275
1354PhosphorylationEEGERMLSTFKELFS
HHHHHHHHHHHHHHH
23.5824719451
1355PhosphorylationEGERMLSTFKELFSE
HHHHHHHHHHHHHHH
34.4624719451
1361PhosphorylationSTFKELFSEKHASLQ
HHHHHHHHHHHHHHH
59.3624719451
1363AcetylationFKELFSEKHASLQNS
HHHHHHHHHHHHHHH
43.1823236377
1363MalonylationFKELFSEKHASLQNS
HHHHHHHHHHHHHHH
43.1826320211
1363UbiquitinationFKELFSEKHASLQNS
HHHHHHHHHHHHHHH
43.1819608861
1366PhosphorylationLFSEKHASLQNSQRT
HHHHHHHHHHHHHHH
30.1530622161
1380PhosphorylationTVAEVQETLAEMIRQ
HHHHHHHHHHHHHHH
17.7424425749
1390UbiquitinationEMIRQHQKSQLCKST
HHHHHHHHHHHHHHC
37.74-
1391PhosphorylationMIRQHQKSQLCKSTA
HHHHHHHHHHHHHCC
23.0918077418
1403AcetylationSTANGPDKNEPEVEA
HCCCCCCCCCCCCCC
67.3626051181
1416PhosphorylationEAEQPLCSSQSQCKE
CCCCCCCCCHHHHHH
38.8125159151
1417PhosphorylationAEQPLCSSQSQCKEE
CCCCCCCCHHHHHHH
32.6221815630
1419PhosphorylationQPLCSSQSQCKEEKN
CCCCCCHHHHHHHCC
39.2228555341
1422AcetylationCSSQSQCKEEKNEPL
CCCHHHHHHHCCCCC
62.3626051181
1425AcetylationQSQCKEEKNEPLSLP
HHHHHHHCCCCCCHH
68.6426051181
1425UbiquitinationQSQCKEEKNEPLSLP
HHHHHHHCCCCCCHH
68.64-
1430PhosphorylationEEKNEPLSLPELTKR
HHCCCCCCHHHHHHH
53.2220873877
1435PhosphorylationPLSLPELTKRLTEAN
CCCHHHHHHHHHHHH
16.6829083192
1436UbiquitinationLSLPELTKRLTEANQ
CCHHHHHHHHHHHHH
59.02-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of GEMI5_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of GEMI5_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of GEMI5_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DDX20_HUMANDDX20physical
11714716
GEMI4_HUMANGEMIN4physical
11714716
GEMI2_HUMANGEMIN2physical
11714716
SMN_HUMANSMN1physical
11714716
SMD1_HUMANSNRPD1physical
11714716
SMD2_HUMANSNRPD2physical
11714716
SMD3_HUMANSNRPD3physical
11714716
RUXE_HUMANSNRPEphysical
11714716
RUXF_HUMANSNRPFphysical
11714716
RUXG_HUMANSNRPGphysical
11714716
GEMI2_HUMANGEMIN2physical
23221635
SMN_HUMANSMN1physical
23221635
GEMI6_HUMANGEMIN6physical
23221635
GEMI4_HUMANGEMIN4physical
23221635
DDX20_HUMANDDX20physical
23221635
IF4E_HUMANEIF4Ephysical
16739988
M3K5_HUMANMAP3K5physical
17541429
MK08_HUMANMAPK8physical
17541429
MP2K4_HUMANMAP2K4physical
17541429
PLOD1_HUMANPLOD1physical
22863883
DDX20_HUMANDDX20physical
24923560
NSD2_HUMANWHSC1physical
24923560
TISD_HUMANZFP36L2physical
26496610
DDX3X_HUMANDDX3Xphysical
26496610
DECR_HUMANDECR1physical
26496610
ERF1_HUMANETF1physical
26496610
GOGA4_HUMANGOLGA4physical
26496610
PFD1_HUMANPFDN1physical
26496610
SMN_HUMANSMN1physical
26496610
RU17_HUMANSNRNP70physical
26496610
SMD1_HUMANSNRPD1physical
26496610
SMD2_HUMANSNRPD2physical
26496610
SMD3_HUMANSNRPD3physical
26496610
THIO_HUMANTXNphysical
26496610
H2A2A_HUMANHIST2H2AA3physical
26496610
GEMI2_HUMANGEMIN2physical
26496610
STRAP_HUMANSTRAPphysical
26496610
DDX20_HUMANDDX20physical
26496610
LPIN1_HUMANLPIN1physical
26496610
GEMI4_HUMANGEMIN4physical
26496610
UBR5_HUMANUBR5physical
26496610
GEMI8_HUMANGEMIN8physical
26496610
GEMI7_HUMANGEMIN7physical
26496610
GEMI6_HUMANGEMIN6physical
26496610
SYNCI_HUMANSYNCphysical
26496610
LSM11_HUMANLSM11physical
26496610

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of GEMI5_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1363, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; THR-751; SER-770;SER-778; THR-807 AND SER-847, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-778, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-778, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-807, AND MASSSPECTROMETRY.

TOP